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A B S T R A C T   
Background: Whilst the resection margin is an established factor predictive of local control of soft-tissue sarcomas 
(STSs), the adequacy of margin width for low-grade STSs has been rarely described. We aimed to investigate the 
margin adequacy and its prognostic relevance in low-grade STSs. 
Methods: 109 patients who underwent surgical treatment for a low-grade STS were studied. The prognostic value 
of margin status was evaluated according to the R–, R+1–classification, and width in millimetres. 
Results: The 10-year local recurrence (LR) rates were 6%, 27%, 54% in R0, R1, and R2, respectively (p < 0.001), 
according to the R–classification. The R+1–classification resulted in a decreased LR rate in R1, but no major 
differences in LR rates in R0 and R2; 7%, 14%, 54% in R0, R1, and R2, respectively (p < 0.001). When classified 
by metric distance, 10-year LR rates were 0%, 8%, and 38% by ≥ 2.0 mm, 0.1–1.9 mm, and 0 mm margins, 
respectively (p < 0.001). Patients with close margins (0.1–1.9 mm) who received adjuvant radiotherapy had a 
trend toward lower LR risk than those without radiotherapy (10-year, 4% vs. 12%; p = 0.406). The 5 and 10-year 
disease-specific mortality was 9% and 13%, respectively; margin width was not associated with disease-specific 
mortality but LR was a poor prognostic factor for survival (p = 0.003). 
Conclusion: Whilst negative margin provided local control over 90%, excellent local control was achieved with 
microscopic margins ≥2 mm. The role of margins is more important than radiotherapy in local control. Margins 
do not determine survival, but LR is associated with a poor prognosis.   
1. Introduction 
Surgery is the mainstay of treatment for localised soft-tissue sar-
comas (STSs) [1,2]. The primary aim of surgery is complete tumour 
excision with a margin of normal tissue aiming to achieve with wide 
resection margins [3], and a positive resection margin is a 
well-established risk factor for local recurrence (LR) [4–6]. However, 
there is no consensus or guideline on the width of resection margin 
needed to optimise local control for STSs [3,7]. In the recent decades, 
several researchers have investigated the extent of resection margins [4, 
6–16]. Many descriptions regarding margin adequacy have been found 
from negative (>0 mm) margin [14,17,18] to 3 cm [11] or even 5 cm [6, 
8]. This inconsistency might be due to a selection bias in each study, 
consisting of a heterogeneous population of low-grade and high-grade 
STSs, or infiltrative and non-infiltrative STSs. It is worth noting that 
investigations for low-grade STSs have been rarely performed and, thus, 
the question of what margin for low-grade STSs is adequate remains 
unclear. 
The clinical guidelines for low-grade STSs recommend the appro-
priate resection margins for specific subtypes such as dermatofi-
brosarcoma protuberance (DFSP) and atypical lipomatous tumour 
(ALT)/well-differentiated liposarcoma (WDLS) [19]. DFSP is a low- 
grade cutaneous STS, characterised by infiltrative local invasion asso-
ciated with a high risk of LR [19]. The National Comprehensive Cancer 
Network (NCCN) guidelines recommend ‘surgical margins with 2–4 cm 
to include fascia is preferred when clinically feasible’ [20,21]. 
ALT/WDLS is a relatively common subgroup of lipomatous STS with no 
potential for distant metastasis without evidence for dedifferentiation. 
The European Society for Medical Oncology (ESMO) guidelines advo-
cate that marginal margins can be accepted for this subtype [22]. 
However, there is no distinct recommendation on the width of resection 
margin needed for low-grade STSs other than DFSP and ALT/WDLS. 
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The purpose of this study was to investigate the prognostic signifi-
cance of a metric distance of resection margin in low-grade STSs, 
excluding DFSP and ALT/WDLS, and to clarify the width of margin 
required for optimising local control for these tumours. 
2. Patients and methods 
2.1. Patient 
A consecutive series of patients who underwent surgical resection for 
a low-grade STS at a supra-regional, tertiary sarcoma centre between 
1996 and 2016 were evaluated. The histological diagnoses were deter-
mined by the experienced pathologists according to the latest version of 
World Health Organization (WHO) classification [23]. Only patients 
whose tumour was superficial or deep-seated and diagnosed as grade 1 
according to French Federation of Cancer Centres Sarcoma Group 
(FNCLCC)–criteria [24,25] were included. Patients who were diagnosed 
as ALT/WDLS or DFSP were excluded from this study. Patients whose 
pathological details including resection margin in millimetres was un-
available or those who were referred for follow-up after initial treatment 
at another hospital were also excluded. 
The following data were extracted from records: age at diagnosis, 
sex, histopathological diagnosis, tumour site, size, depth, and stage, use 
of adjuvant therapy, resection margin, follow-up data including local 
recurrence (LR) and oncological outcome. Tumour size was determined 
as the greatest diameter of the tumour measured on the resected spec-
imens. Tumour stage was classified according to the UICC 8th classifi-
cation [26]. The closest resection margin in millimetres was evaluated 
by an experienced sarcoma histopathologist after gross and microscopic 
examination of the specimen. The resection margin width was classified 
according to the conventional R-classification (R0, macroscopic and 
macroscopic negative margin; R1, microscopically positive margin or 
marginal resection along a pseudo-capsule; R2, macroscopically positive 
margin) [27], and R+1-classification (R0, margin with ≥ 1 mm; R1, 
margin with <1 mm; R2, macroscopic positive margin) [28], and also 
categorised according to the results regarding the correlation between 
the margin width and LR. 
Biopsy was routinely performed preoperatively at our institution. 
Diagnosis and treatment decisions were discussed and determined at a 
weekly multidisciplinary team meeting. Our basic policy for low-grade 
STSs was wide excision with the surrounding normal tissues. If the 
resection margin was intralesional, marginal, or close to marginal, 
adjuvant radiation therapy was indicated. This study was approved by 
the institutional review board and all data was collected from the clin-
ical records and imaging systems as part of routine patient follow-up. 
2.2. Statistical analysis 
Outcome measures included LR and disease-specific mortality. Crude 
cumulative incidence for LR and a disease-specific death was estimated 
using a competing risk analysis. Death or metachronous distant metas-
tases, whichever occurred first, was regarded as a competing event to 
LR. Other causes of death were regarded as competing risks to disease- 
specific mortality. Multivariate analysis was performed using Fine and 
Gray model and calculated sub-distribution hazard ratios (HRs) for the 
final predictor variables [29–31]. All statistical analyses were performed 
using the using the R version 3.5.5. Differences were considered to be 
statistically significant at p < 0.05. 
3. Results 
3.1. Patient characteristics 
The study cohort consisted of 109 patients. The details of patient 
demographics and treatments are summarised in Table 1. The median 
age at diagnosis was 49 years (Interquartile range [IQR], 37–65 years). 
There was a slight male predominance (n = 66; 61%). The most common 
primary site was upper extremity (n = 67; 61%), followed by trunk (n =
23; 21%) and lower extremity (n = 19; 17%). The histological diagnosis 
included myxoid liposarcoma in 42 patients (39%), undifferentiated/ 
unclassified sarcoma in 19 (17%), myxofibrosarcoma in 16 (15%), low- 
grade fibromyxoid sarcoma in 9 (8%), leiomyosarcoma in 8 (7%), and 
others (Table 1). The median size of the tumour was 7.1 cm (IQR, 
4.5–13.0 cm). Adjuvant radiotherapy was performed in 46 patients 
(42%). 
3.2. Resection margin width in millimetres and local control 
The correlations between LR and resection margin in millimetres are 
summarised in Table 2. The LR rate in this cohort was 15% (n = 16); 
38% (n = 12) in patients with positive margin and 5% (n = 4) with 
negative margin (p < 0.001). In patients with negative margin, the LR 
rate was 6% and 8% in 0.1–0.9 mm and 1.0–1.9 mm, respectively, but no 
LR was observed in ≥2.0 mm margin. 
The 5 and 10-year crude cumulative incidence of LR in this cohort 
was 15% and 16%, respectively. By the R-classification, the 10-year 
cumulative incidence of LR was 6%, 27%, 54% in R0, R1, and R2 
margin, respectively (p < 0.001; Fig. 1A). By the R+1-classification, the 
10-year cumulative incidence of LR was 7%, 14%, and 54% in R0, R1, 
and R2 margin, respectively (p < 0.001; Fig. 1B). The cumulative LR 
incidence with R0 resection by R- and R+1-classification was similar, 
indicating that the margin width less than 1 mm could not distinguish 
the risk of LR in patients with negative margin. When we divide patients 
into three groups of resection margin according to the results in Table 1, 
the 10-year cumulative incidence of LR was 0%, 8%, and 38% by ≥ 2.0 
mm, 0.1–1.9 mm, and 0 mm, respectively (p < 0.001; Fig. 1C). 
The univariate analysis for Fine and Gray sub-distribution hazard 
model revealed that surgical margin (R-, R+1-classification, and our 
classification) was significantly associated with the LR (Supplementary 
Table 1). We then performed multivariate analysis separately for R- 
classification, R+1-classification, and the three-group classification 
using the Fine and Gray subdistribution hazard model. In all cases, the 
resection margin and tumour depth were identified as a significant 
Table 1 
Patient characteristics.  




Total  109 – 
Age at diagnosis (median, IQR) 49 37–65 
Gender Male 66 61% 
Female 43 39% 
Site Upper extremity 67 61% 
Lower extremity 19 17% 
Trunk 23 21% 
Depth Deep 74 68% 
Superficial 35 32% 




Myxofibrosarcoma 16 15% 
Low-grade fibromyxoid sarcoma 9 8% 
Leiomyosarcoma 8 7% 
MPNST 6 6% 




Others 5 5% 
Tumour size ≤5 cm 39 36% 
>5 cm, ≤10 cm 33 30% 
>10 cm 37 34% 
Chemotherapy Yes 1 1% 
No 108 99% 
Radiotherapy Yes 46 42% 
No 63 58%  
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factor, whereas age, sex, tumour size, tumour site, inadvertent treat-
ment, and the use of radiotherapy were not significantly associated with 
LR (Supplementary Table 2). Among three margin classifications, posi-
tive margin or 0.1–1.9 mm margin versus ≥2 mm margin showed the 
most significant hazards for LR compared with R1 or R2 margin versus 
R0 margin in the R- or R+1-classification, respectively (Supplementary 
Table 2). 
3.3. Adjuvant radiotherapy 
Patients with close margins of 0.1–1.9 mm who received adjuvant 
radiotherapy had a trend towards fewer local recurrences than those 
without radiotherapy (10-year, 4% vs. 12%; p = 0.406; Supplementary 
Fig. 1A), despite no significant difference. The efficacy of radiotherapy 
was not seen in patients with positive margins: the 10-year cumulative 
incidence of LR was 39% and 38% in patients with and without radio-
therapy, respectively (p = 0.934; Supplementary Fig. 1B). Regardless of 
the use of radiotherapy, the cumulative LR incidence was clearly strat-
ified by ≥ 2.0 mm, 0.1–1.9 mm, and 0 mm margin (Fig. 2A and B). 
3.4. Resection margin width of millimetres and cause-specific mortality 
The 5 and 10-year cumulative incidence of disease-specific mortality 
was 9% and 13%, respectively, with a median follow-up of 67 months 
(IQR, 39–103 months). The univariate analysis for Fine and Gray sub- 
distribution hazard model revealed that presence of LR was a poor 
prognostic factor for disease-specific mortality (HR 4.580, 95% CI 
1.665–12.600, versus no LR: HR 1; p = 0.003). Resection margin width, 
however, was not significantly correlated with disease-specific mortal-
ity; the 10-year cumulative disease-specific mortality was 23%, 6%, and 
13% in 0 mm, 0.1–1.9 mm, and ≥2.0 mm, respectively (p = 0.414; 
Supplementary Fig. 2). 
4. Discussion 
Although the extent of resection margin for STSs has been investi-
gated in a recent decade [4,6–16], most of these studies are done using 
the patient cohort which consists of a mixture of low-grade and 
high-grade STSs, and studies focusing on low-grade STSs are limited 
(Table 3). Marcus et al. reported that the 5-year probability of LR in 76 
patients with low-grade STSs was 21.4% in patients with positive mar-
gins and 9.8% in patients with negative margins, although this did not 
reach statistical difference (p = 0.076) [32]. Only reports by Kawaguchi 
et al. analysed the adequacy of margin width in low-grade sarcomas. 
They defined a margin with ≥5 cm, more than 1–4 cm, 1 cm, and per-
icapsular reactive zone as a ‘curative’, ‘adequate wide’, ‘inadequate 
wide’, and ‘marginal’ margin [6,8]. In low-grade sarcomas, the adequate 
wide and curative margins achieved >90% local curability (97% and 
91%, respectively), while inadequate wide, marginal, and intralesional 
margins resulted in <80% local curability (76%, 78%, and 48%, 
respectively). However, this study cohort consisted of a mixture of bone 
sarcomas and STSs, including chordoma, parosteal and periosteal oste-
osarcoma and conventional chondrosarcoma, which provides ambig-
uous conclusion regarding the margin adequacy for low-grade STSs. In 
addition, this method applies ‘round-up’ system from millimetres to 
centimetres; resection margin was finalized, for example, as 1 cm if the 
closest margin was 0.1–0.9 cm. Thus, the value of margin in millimetres 
has been unclear to date. This study is, to the best of our knowledge, the 
largest series on low-grade STSs to demonstrate the margin adequacy in 
a metric distance. Our investigation demonstrated that local control 
after 10 years was achieved in 62%, 92%, and 100% in intralesional, 
0.1–1.9 mm, and ≥2.0 mm, respectively. Our data indicates that, 
although local control is expected in >90% of cases with clear margins, a 
resection margin width ≥2.0 mm provides optimal local control. 
Studies suggest the disparate surgical margin width of resection 
specimens between the unfixed and fixed state. Horn et al. investigated 
the possible shrinkage effects of formalin fixation on breast cancer 
specimens. They found that there were significant changes in the dis-
tance to all surgical resection margins from the unfixed to fixed state, 
resulting in a 15%–22% loss of mean distance [33]. Goldstein et al. 
investigated the shrinkage of the resected colorectal specimens and re-
ported that these specimens shrank by 57% of the in vivo length after 
formalin fixation [34]. Given that this shrinkage also occurs in STSs, the 
microscopic ‘2 mm’ margin, which minimised the risk of LR in this 
study, could be equivalent to ‘4–5 mm’. In addition, there is also 
shrinkage of normal muscle or adipose tissue around the tumour just 
after resecting out from the tumour site. Therefore, aiming for an at least 
1 cm margin in the surgical field, considering a possible shrinkage down 
to the microscopic 2 mm margin, could be safer to minimise the risk of 
local failure for low-grade STSs. 
In this study, we identified a trend toward better local control with 
adjuvant radiotherapy in patients with margins of 0.1–1.9 mm. In a 
retrospective study of 132 patients with low-grade STSs, Choong et al. 
described a beneficial effect of radiotherapy on tumours that had been 
excised with marginal margins; LR occurred in 6 of 9 patients (67%) who 
did not receive radiotherapy while no LR in 24 patients who received 
radiotherapy (p = 0.0008) [35]. The definition of marginal and wide 
resections was not described, and are inherently subjective and may 
vary depending on reporter, it is difficult to make clear conclusions on 
what width of margin is rescued by adjuvant radiotherapy. Although 
further investigation is needed, adjuvant radiotherapy might play a role 
on tumours which is excised with very close margins. Of note, our data 
demonstrated no benefit of adjuvant radiotherapy in patients with 
intralesional margin, indicating that the role of surgical margin appears 
to be more crucial than radiotherapy for low-grade STSs. 
We acknowledge several limitations to this study. First, the details of 
adjuvant radiotherapy including radiation dose or radiated field were 
not fully available and could not be assessed, because our institute is a 
supra-regional surgical centre for bone and soft-tissue tumours. Second, 
this study has a retrospective nature with a limited number of patients. 
Thus, further analyses based on a larger cohort of patients would be 
necessary for more precise analysis. Third, this study cohort consists of a 
variety of histological diagnosis, even focused on low-grade tumours. 
Fourth, the margin quality was not analysed in this study. Further 
analysis considering with margin quality would provide more precise 
stratification for low-grade STSs. 
5. Conclusion 
This study, the largest study that reports the margin adequacy for 
Table 2 
Local recurrence according to the surgical margin width and the use of radiotherapy.  
Margin width Total Adjuvant RT- Adjuvant RT+
LR+ Total %LR LR+ Total %LR LR+ Total %LR 
0 mm 12 32 38% 6 16 38% 6 16 38% 
0.1–0.9 mm 2 33 6% 1 14 7% 1 19 5% 
1.0–1.9 mm 2 25 8% 2 20 10% 0 5 0% 
≥2.0 mm 0 19 0% 0 13 0% 0 6 0% 
Total 16 109 15% 9 63 14% 7 46 15%  
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low-grade STSs, demonstrated that excellent local control was achieved 
with margins greater than 2 mm, although negative margins provided 
local control of over 90%. The role of margins is more important than 
radiotherapy in local control for low-grade STSs. Margins do not 
determine survival, but LR is associated with a poor prognosis. 
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distance of margin in patients who received adjuvant radiotherapy (A) and did 
not (B). 
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